Scientists investigate how eczema drug tralokinumab affects the skin
NCT ID NCT05378698
First seen Feb 06, 2026 · Last updated May 01, 2026 · Updated 9 times
Summary
This study looked at how the drug tralokinumab works in the skin of people with moderate to severe eczema (atopic dermatitis). Researchers measured drug levels in skin samples after 16 weeks of treatment to better understand its effects. The goal was to learn which patients might benefit most from this therapy. The study included 24 adults and was terminated early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Allergy Unit, Dept. of Dermatology, Unviersity Hosptial of Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.